Mitigating the risk of HIV infection with opioid substitution treatment.
作者信息
Gowing Linda R, Hickman Matthew, Degenhardt Louisa
机构信息
DASSA-WHO Collaborating Centre for Research in the Treatment of Drug and Alcohol Problems, The University of Adelaide, Adelaide, SA 5005, Australia.
出版信息
Bull World Health Organ. 2013 Feb 1;91(2):148-9. doi: 10.2471/BLT.12.109553.
Abstract
摘要
相似文献
1
Mitigating the risk of HIV infection with opioid substitution treatment.通过阿片类药物替代疗法降低艾滋病毒感染风险。
Bull World Health Organ. 2013 Feb 1;91(2):148-9. doi: 10.2471/BLT.12.109553.
2
Opioid treatment in Ukraine risks losing momentum.乌克兰的阿片类药物治疗有失去动力的风险。
Bull World Health Organ. 2013 Feb 1;91(2):87-8. doi: 10.2471/BLT.13.020213.
3
Opioid substitution: improving cost-efficiency.阿片类药物替代疗法：提高成本效益。
Bull World Health Organ. 2013 Feb 1;91(2):83. doi: 10.2471/BLT.13.117374.
4
Scaling up opioid dependence treatment in low- and middle-income settings.在低收入和中等收入地区扩大阿片类药物依赖治疗规模。
Bull World Health Organ. 2013 Feb 1;91(2):82-82A. doi: 10.2471/BLT.12.110783.
5
6
Delivery models of opioid agonist maintenance treatment in South Asia: a good beginning.南亚阿片类激动剂维持治疗的交付模式：良好开端。
Bull World Health Organ. 2013 Feb 1;91(2):150-3. doi: 10.2471/BLT.12.111815.
7
Risk dimensions of HIV-tested substance users.接受HIV检测的药物使用者的风险维度。
Int J Addict. 1993 Dec;28(14):1487-95. doi: 10.3109/10826089309062195.
8
Law enforcement and drug treatment: a culture clash.执法与戒毒治疗：文化冲突。
Science. 2010 Jul 9;329(5988):169. doi: 10.1126/science.329.5988.169.
9
Scale-up of opioid substitution therapy in India: opportunities and challenges.印度扩大阿片类药物替代疗法：机遇与挑战。
Int J Drug Policy. 2012 Mar;23(2):169-70. doi: 10.1016/j.drugpo.2011.11.002. Epub 2012 Jan 26.
10
Harm reduction intensity-Its role in HAART adherence amongst drug users in Amsterdam.减少伤害强度-其在阿姆斯特丹吸毒者中抗逆转录病毒治疗依从性中的作用。
Int J Drug Policy. 2011 May;22(3):210-8. doi: 10.1016/j.drugpo.2011.02.004. Epub 2011 Mar 9.
引用本文的文献
1
Exploration of the multi-level barriers to scaling up methadone for HIV prevention among people who inject drugs in Kazakhstan.哈萨克斯坦扩大美沙酮用于预防注射吸毒者感染艾滋病毒的多层次障碍探索。
J Subst Use Addict Treat. 2025 May;172:209640. doi: 10.1016/j.josat.2025.209640. Epub 2025 Feb 20.
2
Trajectories of medication for opioid use disorder and their impact on HIV testing among people who inject drugs in India: A longitudinal assessment of clinic-based data.印度注射吸毒者阿片类物质使用障碍药物治疗轨迹及其对艾滋病毒检测的影响：基于诊所数据的纵向评估
Addiction. 2025 Apr;120(4):745-755. doi: 10.1111/add.16713. Epub 2024 Nov 27.
3
The burden of skin and soft tissue, bone and joint infections in an Australian cohort of people who inject drugs.澳大利亚注射吸毒人群中的皮肤和软组织、骨和关节感染负担。
BMC Infect Dis. 2024 Mar 7;24(1):299. doi: 10.1186/s12879-024-09143-0.
4
The opioid receptor: emergence through millennia of pharmaceutical sciences.阿片受体：历经数千年药物科学的发展而出现。
Front Pain Res (Lausanne). 2023 Nov 1;4:960389. doi: 10.3389/fpain.2023.960389. eCollection 2023.
5
Should I Stay or Should I Go? A Qualitative Exploration of Stigma and Other Factors Influencing Opioid Agonist Treatment Journeys.我该留下还是离开？定性探讨影响阿片类激动剂治疗旅程的污名化和其他因素。
Int J Environ Res Public Health. 2023 Jan 14;20(2):1526. doi: 10.3390/ijerph20021526.
6
Opioid agonist treatment for people who are dependent on pharmaceutical opioids.阿片类药物成瘾者的阿片类激动剂治疗。
Cochrane Database Syst Rev. 2022 Sep 5;9(9):CD011117. doi: 10.1002/14651858.CD011117.pub3.
7
Six-month buprenorphine-naloxone treatment is associated with neurocognitive function improvement in opioid dependence.六个月的丁丙诺啡-纳洛酮治疗与阿片类药物依赖患者神经认知功能的改善相关。
Indian J Psychiatry. 2022 Mar-Apr;64(2):199-208. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_792_21. Epub 2022 Mar 24.
8
Pre-exposure prophylaxis (PrEP) indication and uptake among people receiving buprenorphine for the treatment of opioid use disorder.在接受丁丙诺啡治疗阿片类药物使用障碍的人群中，暴露前预防 (PrEP) 的适应证和使用率。
J Subst Abuse Treat. 2022 Jan;132:108506. doi: 10.1016/j.jsat.2021.108506. Epub 2021 May 31.
9
Global opioid agonist treatment: a review of clinical practices by country.全球阿片类激动剂治疗：按国家划分的临床实践综述。
Addiction. 2020 Dec;115(12):2243-2254. doi: 10.1111/add.15087. Epub 2020 May 19.
10
Treating opioid dependence with extended-release naltrexone (XR-NTX) in Ukraine: Feasibility and three-month outcomes.在乌克兰使用缓释纳曲酮（XR-NTX）治疗阿片类药物依赖：可行性和三个月的结果。
J Subst Abuse Treat. 2019 Sep;104:34-41. doi: 10.1016/j.jsat.2019.05.008. Epub 2019 May 10.
本文引用的文献
1
Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis.阿片类物质替代治疗与注射吸毒人群中 HIV 的传播：系统评价和荟萃分析。
BMJ. 2012 Oct 3;345:e5945. doi: 10.1136/bmj.e5945.
2
A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs.系统评价和荟萃分析干预措施预防注射吸毒人群感染丙型肝炎病毒。
J Infect Dis. 2011 Jul 1;204(1):74-83. doi: 10.1093/infdis/jir196.
3
Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV.在纽约市注射吸毒者中，单纯疱疹病毒 2 型和 HCV 与 HIV 之间的关联：当前 HIV 性传播的重要性。
Am J Public Health. 2011 Jul;101(7):1277-83. doi: 10.2105/AJPH.2011.300130. Epub 2011 May 12.
4
Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database.在初级保健中接受阿片类药物替代治疗期间和之后的死亡风险：英国普通实践研究数据库的前瞻性观察研究。
BMJ. 2010 Oct 26;341:c5475. doi: 10.1136/bmj.c5475.
5
Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed.预防注射吸毒人群感染 HIV：为什么需要个体、结构和综合方法。
Lancet. 2010 Jul 24;376(9737):285-301. doi: 10.1016/S0140-6736(10)60742-8.
6
HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.HIV 预防、治疗和关爱服务在注射毒品人群中的应用：全球、地区和国家覆盖范围的系统评价。
Lancet. 2010 Mar 20;375(9719):1014-28. doi: 10.1016/S0140-6736(10)60232-2. Epub 2010 Feb 26.
7
Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review.吸毒者中人类免疫缺陷病毒/获得性免疫缺陷综合征抗逆转录病毒治疗的依从性：一项系统评价。
Addiction. 2008 Aug;103(8):1242-57. doi: 10.1111/j.1360-0443.2008.02269.x.
8
Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS.世界卫生组织关于阿片类药物依赖替代疗法与艾滋病毒/艾滋病的合作研究的主要发现。
Addiction. 2008 Sep;103(9):1484-92. doi: 10.1111/j.1360-0443.2008.02249.x. Epub 2008 Jul 10.
9
Substitution treatment of injecting opioid users for prevention of HIV infection.注射阿片类药物使用者的替代治疗以预防艾滋病毒感染。
Cochrane Database Syst Rev. 2008 Apr 16(2):CD004145. doi: 10.1002/14651858.CD004145.pub3.
10
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.美沙酮维持治疗与无阿片类药物替代治疗对阿片类药物依赖的疗效比较
Cochrane Database Syst Rev. 2002(4):CD002209. doi: 10.1002/14651858.CD002209.
Zotero 插件